Forma Therapeutics Holdings, Inc., Stock Price, News & Analysis
Company Description
Forma Therapeutics Holdings, Inc., (NASDAQ: FMTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.0B.
FMTX stock has gained 11.2% over the past year.
This page provides a comprehensive overview of FMTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Forma Therapeutics Holdings, Inc., (FMTX) stock. Over the past 12 months, the stock has gained 11.2%. At a market capitalization of $1.0B, FMTX is classified as a small-cap stock with approximately 47.9M shares outstanding.
Latest News
Forma Therapeutics Holdings, Inc., has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences, management. View all FMTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
FMTX Company Profile & Sector Positioning
Forma Therapeutics Holdings, Inc., (FMTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing FMTX often look at related companies in the same sector, including Mimedx Group Inc (MDXG), Oric Pharmaceuticals, Inc. (ORIC), Sionna Therapeutics (SION), Pharming Group N.V. (PHAR), and Maravai Lifesciences Holdings, Inc. (MRVI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FMTX's relative position within its industry.